Moleculin Biotech, Inc.Moleculin Biotech, Inc.Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

No trades
See on Supercharts
Market capitalization
‪10.31 M‬USD
−15.10USD
‪−29.77 M‬USD
‪2.15 M‬
Beta (1Y)
1.18

About Moleculin Biotech, Inc.

CEO
Walter V. Klemp
Headquarters
Houston
Employees (FY)
18
ISIN
US60855D3098
FIGI
BBG00B9T47L9
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MBRX is 4.63 USD — it has decreased by 3.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Moleculin Biotech, Inc. stocks are traded under the ticker MBRX.
Moleculin Biotech, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Moleculin Biotech, Inc. has a max estimate of 40.00 USD and a min estimate of 20.00 USD.
MBRX earnings for the last quarter are −2.85 USD whereas the estimation was −3.35 USD which accounts for 14.93% surprise. Estimated earnings for the next quarter are −3.23 USD. See more details about Moleculin Biotech, Inc. earnings.
Yes, you can track Moleculin Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MBRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moleculin Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MBRX reached its all-time high on Jun 6, 2016 with the price of 862.20 USD, and its all-time low was 4.34 USD and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 15, 2024, the company has 18.00 employees. See our rating of the largest employees — is Moleculin Biotech, Inc. on this list?